Heartbeam Inc (BEAT)

Currency in USD
2.390
+0.030(+1.27%)
Closed·
2.4000.000(0.00%)
·
BEAT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.2302.400
52 wk Range
0.5404.000
Key Statistics
Prev. Close
2.36
Open
2.34
Day's Range
2.23-2.4
52 wk Range
0.54-4
Volume
1.39M
Average Volume (3m)
12.6M
1-Year Change
10.8%
Book Value / Share
0.01
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BEAT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.625
Upside
+93.51%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Heartbeam Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Heartbeam Inc Company Profile

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.

Heartbeam Inc Earnings Call Summary for Q3/2025

  • HeartBeam reported Q3 2025 net loss of $5.3M with EPS of -$0.15, missing forecasts by 87.5%, causing shares to drop 5.99% and an additional 1.44% in aftermarket trading.
  • The company's cash position stands at $1.9M with operating cash burn of $3.2M, an 8% decrease quarter-over-quarter, raising concerns about financial sustainability.
  • HeartBeam anticipates FDA clearance for its 12-lead ECG synthesis by year-end, with commercial launch planned for early 2026 and modest growth projected for H1 2026.
  • CEO Rob Eno emphasized the 'transformative potential' of HeartBeam's cardiac care technology as the company transitions to a commercial entity for the first time in 2026.
  • Despite securing initial FDA clearance and having a robust patent portfolio, the company faces challenges with financial stability, market acceptance, and limited cash reserves.
Last Updated: 2025-11-13, 05:28 p/m
Read Full Transcript

Compare BEAT to Peers and Sector

Metrics to compare
BEAT
Peers
Sector
Relationship
P/E Ratio
−4.0x−59.5x−0.6x
PEG Ratio
−0.77−0.090.00
Price/Book
202.8x18.6x2.6x
Price / LTM Sales
-5.0x3.3x
Upside (Analyst Target)
101.3%32.5%40.0%
Fair Value Upside
Unlock−7.3%3.2%Unlock

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 4.625
(+93.51% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Benchmark
Buy8.00+234.73%-UpgradeDec 11, 2025
H.C. Wainwright
Buy5.50+130.13%2.50MaintainDec 11, 2025
H.C. Wainwright
Buy2.50+4.60%-New CoverageDec 08, 2025
Roth/MKM
Buy4.00+67.36%-New CoverageOct 31, 2025
Benchmark
Buy8.00+234.73%-MaintainAug 29, 2025

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
-0.15 / -0.08
Revenue / Forecast
-- / 2.63M
EPS Revisions
Last 90 days

BEAT Income Statement

People Also Watch

12.79
PLRZ
-4.62%
1.3800
INHD
-11.54%
67.08
AFJK
+0.10%

FAQ

What Is the Heartbeam (BEAT) Stock Price Today?

The Heartbeam stock price today is 2.390

What Stock Exchange Does Heartbeam Trade On?

Heartbeam is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Heartbeam?

The stock symbol for Heartbeam is "BEAT."

What Is the Heartbeam Market Cap?

As of today, Heartbeam market cap is 81.29M.

What Is Heartbeam's Earnings Per Share (TTM)?

The Heartbeam EPS (TTM) is -0.66.

When Is the Next Heartbeam Earnings Date?

Heartbeam will release its next earnings report on Mar 19, 2026.

From a Technical Analysis Perspective, Is BEAT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Heartbeam Stock Split?

Heartbeam has split 0 times.

How Many Employees Does Heartbeam Have?

Heartbeam has 16 employees.

What is the current trading status of Heartbeam (BEAT)?

As of Jan 10, 2026, Heartbeam (BEAT) is trading at a price of 2.390, with a previous close of 2.360. The stock has fluctuated within a day range of 2.230 to 2.400, while its 52-week range spans from 0.540 to 4.000.

What Is Heartbeam (BEAT) Price Target According to Analysts?

The average 12-month price target for Heartbeam is USD4.625, with a high estimate of USD8 and a low estimate of USD1. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +93.51% Upside potential.

What Is the BEAT Premarket Price?

BEAT's last pre-market stock price is 2.350. The pre-market share volume is 38,650.000, and the stock has decreased by -0.010, or -0.420%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.